Summaries for Carcinoma

Sources:
6Disease Ontology, 44Wikipedia, 22MalaCards
See all sources

Export this MalaCard
Disease Ontology: A cell type cancer that has material basis in abnormally proliferating cells derived from epithelial cells.6

MalaCards: Carcinoma, also known as epithelioma, is related to hepatocellular carcinoma and thyroiditis. An important gene associated with Carcinoma is MUC1 (mucin 1, cell surface associated), and among its related pathways are Tec Kinases Signaling and Pancreatic Adenocarcinoma. The drugs carmustine and diethylstilbestrol diphosphate and the compounds phospholipid and haloperidol have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, whole blood and lymph node, and related mouse phenotypes are homeostasis/metabolism and endocrine/exocrine gland.

Wikipedia: Carcinoma (Gk. karkinos, or \"crab\", and -oma, \"growth\") is the medical term for the most common type...44 more...

Aliases & Descriptions for Carcinoma

Sources:
6Disease Ontology, 7diseasecard, 8DISEASES, 32Novoseek , 43UMLS, 40SNOMED-CT, 24MeSH, 27NCIt
See all sources

Aliases & Descriptions:

carcinoma 6 8 32 43
epithelioma 6 7
epithelioma, malignant (morphologic abnormality) 6
malignant epithelioma 6

Related Diseases for Carcinoma

Sources:
13GeneCards, 14GeneDecks
See all sources

Diseases related to carcinoma by text searches and GeneDecks gene sharing:

(show top 50)    (show all 1616)
idRelated DiseaseScoreTop Affiliating Genes
1hepatocellular carcinoma504.7ZNF148, ZNF384, ZNF689, ZNF592, PIGR, PIK3CB
2thyroiditis503.2ZNF197, ZNF79, PIK3CB, PIGF, PIK3CA, PIK3R1
3prostatitis502.2ZNF608, ZNF673, ZNF79, ZNF652, PIK3CB, PIP
4esophagitis501.3ZNF673, ZNF410, ZNF639, ZNF207, PIK3CB, PIK3CA
5pancreatitis500.6ZNF146, ZNF148, PIK3CB, PIK3CD, PIK3CA, PIK3R3
6adenocarcinoma499.3ZNF217, ZNF148, PIGR, PIK3CB, PIP, PIM2
7melanoma497.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
8neuronitis496.9ZNF148, ZNF384, PIK3CB, PIK3CD, PI4K2A, PIK3CA
9leukemia495.7ZNF673, ZNF384, PIK3CB, PIK3CD, PIM2, PIK3CA
10colorectal cancer495.3ZNF146, ZNF217, ZNF135, PIGR, PIK3CB, PIK3CD
11gastric cancer494.3ZNF148, ZNF189, PIK3CB, PIK3CA, PIK3R1, PIAS1
12breast carcinoma488.7ZNF217, ZNF202, PIKFYVE, PIP, PIK3CA, PIK3R1
13colon cancer463.4PIK3CB, PIK3CA, PIK3R3, PIK3R1, PIM3, PIAS1
14cervicitis461.4ZNF217, ZNF384, PIK3CA, PIK3CG, PIN1, LRIG1
15hypoxia442.8ZNF217, ZNF354A, PIK3CB, PIK3CD, PIGF, PIK3CA
16neuroblastoma428.7ZNF121, PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3CG
17alzheimer's disease426.2PIK3CB, PIK3CD, PI4K2A, PIK3CA, PIK3R1, PIK3CG
18arthritis423.9PIK3CD, PIK3CG, PIN1, LRP1, LRP2, KL
19rheumatoid arthritis385.3PIK3CD, PIK3CG, PIN1, LRP1, LRP2, KL
20cholesterol379.4ZNF202, PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1
21adenoma377.1ZNF410, PIK3CA, PIM3, KLF4, NCAM1, NCF2
22sarcoma374.9ZNF384, PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1
23fibrosis371.5PIK3CA, PIAS3, PIK3CG, PIN1, PI3, LRP1
24cerebritis354.3PIGF, PIK3R1, PIK3C2A, PIK3CG, LRP1, LRP2
25ovarian carcinoma351.7PIKFYVE, PIP, PIGF, PIK3CA, PIK3CG, PI3
26retinitis349.0PIGF, PIK3CA, PIK3C2A, PIK3CG, PIM1, LRAT
27myeloid leukemia341.0ZNF673, PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3R3
28colon carcinoma337.0ZNF146, PIGR, PIK3CB, PIK3CA, PIK3R2, PIK3R1
29myeloma332.5PIM2, PIK3CA, PIAS3, PIK3R2, PIK3R1, PIK3CG
30hypertension320.4ZNF652, PIK3CB, PIK3R1, PIK3C2B, PIK3C2A, PIK3CG
31tuberculosis303.4PIM2, PIK3CG, PIM1, NCEH1, PDCD1, PDCD1LG2
32diabetes mellitus296.1ZNF673, PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2
33obesity295.5PIK3CB, PIK3CA, PIK3R1, PIK3C2A, PIK3CG, LRP1
34lung carcinoma293.3PIK3CA, PIK3R1, PIK3CG, LRP1B, KLF6, NCAM1
35ischemia292.4ZNF354A, PIGF, PIK3CA, PIK3C2A, PIK3CG, KLF4
36cervical cancer289.7ZNF217, PIK3CA, PIK3CG, PIN1, LRIG1, RFC1
37lymphocytic leukemia288.4PIK3CD, PIM2, PIK3CA, PIK3CG, PIGU, NCAM1
38asthma276.9PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3CG, PIN1
39multiple sclerosis273.7PIAS1, LRP1, SH3GL2, RFC1, RFC4, RFC5
40prostate carcinoma272.7ZNF79, PIP, PIAS3, PIK3R1, PIK3CG, PIM1
41osteosarcoma269.9PIK3CB, PIK3CA, PIK3CG, KLF10, RFC1, NCOA1
42gonococcal synovitis267.1PIGR, PIK3CB, PIK3CA, PIK3R1, PIK3CG, PI3
43oral squamous cell carcinoma266.9ZNF510, PIK3CA, PIDD, PIK3C2A, PIN1, PIM1
44multiple myeloma265.9PIK3CA, PIAS3, PIK3R2, PIK3R1, PIK3CG, LRP1
45esophageal squamous cell carcinoma265.2ZNF673, ZNF410, ZNF639, PIK3CA, PIN1, PIM1
46astrocytoma252.8PIK3CA, PIK3R1, PIK3CG, LRP1, KLF6, NCAM1
47acute myeloid leukemia244.8ZNF673, PIK3CB, PIK3CD, PIM2, PIK3CA, PIK3R3
48nasopharyngitis243.5PIGR, PIK3CA, PIK3CG, LRRC4, KLF5, KLF6
49pneumonia240.8PIGR, PIK3C2A, PI3, KL, PDE4A, RELA
50nephropathy239.2PIGR, LRP1, LRP2, LRPAP1, PDCD1, REG1A

Graphical network of the top 20 diseases related to carcinoma:



Graphical network of diseases related to carcinoma

Clinical Features for Carcinoma

Drugs & Therapeutics for Carcinoma

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Approved drugs:

Search CenterWatch for carcinoma

Drug clinical trials:

Search ClinicalTrials for carcinoma

Search NIH Clinical Center for carcinoma

Search CenterWatch for carcinoma

Inferred drug relations via UMLS/NDF-RT:

43 28 carmustine, diethylstilbestrol, diethylstilbestrol diphosphate, nilutamide

Genetic Tests for Carcinoma

Anatomical Context for Carcinoma

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to carcinoma:

22
Bone marrow, Whole blood, Lymph node, Spleen, Thymus, Brain, Cortex, Spinal cord, Heart, Smooth muscle, Skeletal muscle, Small intestine, Colon, Adipocyte, Kidney, Liver, Lung, Pancreas, Thyroid, Salivary gland, Adrenal gland, Breast, Skin, Ovary, Uterus, Placenta, Prostate, Testis, Cervix, Tonsil, Myeloid, Monocytes, Dentritic cells, Nk cells, T cells, B cells, Endothelial, Fetal brain, Parietal lobe, Temporal lobe, Hypothalamus, Caudate nucleus, Cardiac myocytes, Tongue, Fetal liver, Fetal lung, Trachea, Bronchial epithelium, Appendix, Fetal thyroid, Pancreatic islet, Adrenal cortex, Pineal, Pituitary, Uterus corpus, Testis germ

Phenotypes for genes affiliated with Carcinoma

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to carcinoma:

25 (show all 29)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1homeostasis/metabolism phenotypeMP:0005376INFZNF148, PIKFYVE, PIGR, PIK3CB, PIK3CD, PI4K2A
2endocrine/exocrine gland phenotypeMP:0005379INFZNF148, ZNF384, LRIG1, , LRPAP1, KL
3hearing/vestibular/ear phenotypeMP:0005377INF, LRP6, LRRC4, NCOA3, KIT, KITLG
4renal/urinary system phenotypeMP:0005367INFPI4K2A, , LRP6, LRPAP1, KL, NCK1
5mortality/agingMP:0010768INFZNF148, PIKFYVE, PIK3CB, PI4K2A, PIK3CA, PIAS1
6immune system phenotypeMP:0005387INFZNF148, PIGR, PIK3CD, PIM2, PIM3, PIAS1
7craniofacial phenotypeMP:0005382INFLRIG1, , LRP6, SH3BP2, KLF4, NCOA3
8nervous system phenotypeMP:0003631INFZNF148, PI4K2A, LRIG1, LRAT, LRP1, LRP6
9behavior/neurological phenotypeMP:0005386INFPI4K2A, PIK3CA, LRP1, , LRP6, LRRC4
10no phenotypic analysisMP:0003012INFPIK3CD, PIK3R1, PIK3C2B, , LRP6, NDN
11respiratory system phenotypeMP:0005388INF, LRP6, SH3BP2, KL, KLF5, NDN
12limbs/digits/tail phenotypeMP:0005371INFLRIG1, LRP6, KL, KLF10, RECK, RECQL4
13liver/biliary system phenotypeMP:000537099.7LRP6, SH3BP2, KLF6, NCOA3, NCOR1, NCOR2
14adipose tissue phenotypeMP:000537587.1PIK3CA, PIK3R1, PIK3C2A, LRP1, LRP6, KL
15tumorigenesisMP:0002006INFPIK3CB, PIK3CA, PIK3R2, PIK3R1, PINX1, LRIG1
16cellular phenotypeMP:0005384INFZNF148, PIKFYVE, PIK3CB, PIK3CD, PIM2, PIK3CA
17digestive/alimentary phenotypeMP:0005381INFZNF148, PIGR, LRIG1, , LRP6, SH3BP2
18cardiovascular system phenotypeMP:0005385INFZNF148, PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1
19muscle phenotypeMP:0005369INFPIK3CA, PIK3R2, PIK3R1, PIK3CG, LRP1, SH3BP2
20reproductive system phenotypeMP:0005389INFZNF148, ZNF384, PIGR, PI4K2A, PIK3CA, LRAT
21embryogenesis phenotypeMP:0005380INFZNF148, PIKFYVE, PIK3CB, PIK3CA, PIR, PINX1
22vision/eye phenotypeMP:0005391INFPIK3CA, PIN1, LRAT, , LRP6, SH3BP2
23integument phenotypeMP:0010771INFZNF148, PIK3C2B, PIK3CG, PIN1, PINX1, LRIG1
24hematopoietic system phenotypeMP:0005397INFPIGR, PIM2, PIM3, PINX1, PIM1, SH3BP2
25growth/size phenotypeMP:0005378INFZNF148, ZNF384, PIK3CB, PI4K2A, PIM2, PIK3CA
26pigmentation phenotypeMP:0001186INFRFWD2, PDE3B, RECQL4, KIT, KITLG, BTD
27normal phenotypeMP:0002873INFZNF148, PI4K2A, PIK3R1, PIM3, PIDD, LRIG1
28skeleton phenotypeMP:0005390INFZNF384, PIK3CD, PIK3CG, LRP1, , LRP6
29other phenotypeMP:0005395INFLRPAP1, KL, RECK, RELB, CNR1, VPS35

Publications for genes affiliated with Carcinoma

Sources:
35PubMed
See all sources

Articles related to carcinoma:

(show top 50)    (show all 34102)
idTitleAuthorsYearAffiliating Genes
1Elevated expression of squamous cell carcinoma antige n (SCCA) is associated with human breast carcinoma. (21526154)Catanzaro J.M.... Zong W.X.2011SERPINB3
2Synchronous squamous cell carcinoma of the kidney, sq uamous cell carcinoma of the ureter, and sarcomatoid carcinoma of the urinary b ladder: a case report. (19766408)Terada T.2010VIM
3Pancreatic acinar cell carcinomas with prominent duct al differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine du ctal carcinoma. (20182344)Stelow E.B.... Klimstra D.S.2010SYP, CEACAM5
4Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast. (19444935)Miki Y.... Sasanoa H.2009CYP19A1, SRD5A1
5High-grade neuroendocrine carcinoma of the lung: comp arative clinicopathological study of large cell neuroendocrine carcinoma and sm all cell lung carcinoma. (19627535)Sun L.... Nakajima T.2009VIL1
6Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. (19411807)Rotondi M.... Chiovato L.2009RET
7Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas. (18835627)Pryor J.G.... Xu H.2009IGF2BP3
8Invasive breast carcinoma with features of neuroendo crine carcinoma and carcinoma with osteoclastic cells: fine-needle aspiration c ytology and histology of two cases (18841823)Pagani A.... Iandolo M.2008ENO2
9Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report. (18319561)Kanamoto M.... Shimada M.2008KRT20
10Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. (18364444)Zhang H.... Xiao X.2008S100A7
11Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma. (17448197)Li N.... Argenyi Z.2007MUC1, SYP, CEACAM3
12Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. (17649807)Jeschke U.... Friese K.2007CDH1
13High frequency of coexistence of columnar cell lesion s, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubu lar carcinoma and invasive lobular carcinoma. (17325484)Abdel-Fatah T.M.... Ellis I.O.2007CDH1
14Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. (17761983)Agulnik M.... Siu L.L.2007ERBB2, EGFR
15Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component. (17238183)Ohtsuka K.... Watanabe T.2007EGFR
16Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. (16645205)Sugai T.... Nakamura S.2006APC
17Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma. (16740034)Butnor K.J.... Cagle P.T.2006MME
18Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique. (16280664)Pan C.C.... Ho D.M.2005MME, INHA
19Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach. (16254038)Honda T.... Motoyama T.2005PSG2
20Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. (15706409)Jeschke U.... Friese K.2005PAEP
21Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas. (15657565)Sarkaria I.S.... Singh B.2004DCUN1D1
22Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma. (15010880)Yamamoto J.... Kikuchi M.2004CDH1, ENO2, NCAM1
23A rare case of a neuroendocrine carcinoma of the esophagus. Intermediate between a well-differentiated neuroendocrine carcinoma and a low-differentiated neuroendocrine carcinoma (15138705)Gumprich T.... MA1ller K.M.2004SYP
24BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. (14602780)Nikiforova M.N.... Nikiforov Y.E.2003BRAF
25Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. (12773976)Shimada H.... Ochiai T.2003SERPINB3
26Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ. (14652811)Yamamoto J.... Kikuchi M.2003ENO2, NCAM1, KRT19
27Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. (12547708)Ibrahim E.C.... Paul P.2003HLA-G
28Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast. (14567723)Xu R.... Perle M.A.2003ERBB2, TP53
29Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. (12459626)Franchi A.... Santucci M.2002KRT7
30Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. (12472285)Wieczorek T.J.... Pinkus G.S.2002NKX2-1
31Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. (12368185)Hopman A.H.... Ramaekers F.C.2002TP53
32E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma. (12395372)Sun W.... Herrera G.A.2002CDH1
33Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. (11175640)Cheuk W.... Chan J.K.2001KRT20, NKX2-1
34Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. (11737309)Frolik D.... Varga Z.2001ERBB2
35A case of collecting duct carcinoma (Bellini duct carcinoma) producing carcinoembryonic antigen (11329960)Inagaki T.... Shinka T.2001CEACAM3
36E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast (11866953)Han A.... Liang Y.2001CTNNB1, JUP, CTNNA1
37Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. (10897329)Buerger H.... BAPcker W.2000CDH1
38Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract. (10810423)Tsubochi H.... Sasano H.2000KRT14, CTNNA1, CEACAM7
39Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus; a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus. (10212809)Okudela K.... Kitamura H.1999TP53, BCL2, PCNA
40Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma. (10023715)Saegusa M.... Okayasu I.1999PGR, ESR1
41Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. (10353737)Brown L.F.... Dvorak H.F.1999VEGFA, DCN, VCAN
42Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. (9426521)Wick M.R.... Swanson P.E.1998S100B, PIP
43Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. (9042291)Chan J.K.... Lau A.L.1997KRT20
44Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines. (9037942)Yabushita H.... Nakanishi M.1996VDR
45Comparative study of the combined effect of HCFU and dipyridamole (DP) in colorectal carcinoma--TS inhibition rate. Kinki Cooperative Study Group of Chemotherapy for Colorectal Carcinoma (8645023)Kanno H.... Yasutomi M.1996TYMS
46Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas. (8950756)Kamisawa T.... Koike .1996ENO2, SYP, CHGA
47Modification of chorionic carcinoma cells by immunomodulators. Cytokines and chorionic carcinoma cells (8672935)Marth C.... Daxenbichler G.1995KITLG, CGB5
48Basaloid carcinoma and keratinizing squamous cell carcinoma of the vulva: a case of two primary carcinomas. (8572644)Kohlberger P.... Breitenecker G.1995KRT8
49Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. (8393682)Klijanienko J.... Caillaud J.M.1993S100B, VIM
50Carcinoma of the thyroid gland with biphasic clinical course and evolution into medullary carcinoma, follicular variant. A case report and immunocytochemical demonstration of the simultaneous presence of calcitonin and thyroglobulin in neoplastic cells (1603426)Carlei F.... D'Alessandro M.1992CALCA, TG

Expression for genes affiliated with Carcinoma

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Carcinoma

Pathways for genes affiliated with Carcinoma

Sources:
36QIAGEN, 38Reactome, 20KEGG, 3Cell Signaling Technology, 10EMD Millipore, 41Thomson Reuters
See all sources

Pathways related to carcinoma according to GeneDecks:

(show top 50)    (show all 367)
idPathwayScoreTop Affiliating Genes
1Tec Kinases Signaling3675.9PIK3R3, PIK3R2, PIK3R1, KITLG, BTC, BTK
2Pancreatic Adenocarcinoma3662.9PIK3R3, PIK3R2, PIK3R1, KIT, KITLG, BTC
3TGF-Beta Pathway3657.0PIK3R3, PIK3R2, PIK3R1, KITLG, BTC, BTK
4p70S6K Signaling3652.9PIK3R3, PIK3R2, PIK3R1, KIT, KITLG, BTC
5Paxillin Interactions3651.8PIK3R3, PIK3R2, PIK3R1, NCK1, KIT, KITLG
6Immune System3850.5PIAS1, NCAM1, PDCD1, PDCD1LG2, REL, KIR2DS5
7Rap1 Pathway3648.8KITLG, BTC, SEMA3A, SEMA5A, SEMA4G, BRAF
8JNK Pathway3648.5ZNF354A, PIK3R1, KIT, KITLG, BTC, BTK
9Rac1 Pathway3648.1PIK3R3, PIK3R2, PIK3R1, NCF2, KITLG, BTC
10IP3 Pathway3642.8PIK3R3, PIK3R2, PIK3R1, KITLG, BTC, BTK
11WNT Signaling3642.7ZNF354A, LRP6, REST, BTRC, VIM, MYC
12CREB Pathway3642.1PIK3R3, PIK3R2, PIK3R1, KIT, KITLG, BTC
13Colorectal Cancer Metastasis3638.4PIK3R3, PIK3R2, PIK3R1, LRP6, BRAF, MYC
14IL-6 Pathway3638.4PIP, PIK3R3, PIAS3, PIK3R2, PIK3R1, PIM1
15Wnt signaling pathway2036.4LRP6, SFRP1, SFRP2, SFRP4, SFRP5, BTRC
16MIF Regulation of Innate Immune Cells3635.8PIP, BTK, BMP1, BMP2, BMP3, BMP4
17MIF Mediated Glucocorticoid Regulation3634.5PIP, BTK, BMP1, BMP2, BMP3, BMP4
18Chemokine Signaling3634.2PIK3R3, PIK3R2, PIK3R1, BCAR1, XCL1, JUN
19Natural killer cell mediated cytotoxicity2032.8PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
20Actin Nucleation by ARP-WASP Complex3632.8NCK1, WASL, KIT, LMTK3, MYH1, MYO6
21G12-G13 in Cellular Signaling3632.3PIK3R3, PIK3R2, PIK3R1, BTK, VAV2, RAC3
22T cell receptor signaling pathway2031.9PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
23Wnt / Hedgehog / Notch331.3LRP6, KLF4, SFRP1, RBPJ, NANOG, BRD2
24TCR Signaling3630.7PIK3R3, PIK3R2, PIK3R1, VAV2, RAC3, RAF1
25Melanogenesis2028.4KIT, KITLG, RAF1, LEF1, FZD1, FZD10
26Transcription Androgen Receptor nuclear signaling1027.7NCOA1, NCOA2, NCOR1, RAF1, RAD9A, PAK6
27Germ Cell-Sertoli Cell Junction Dynamics3627.4PIK3R3, PIK3R2, VCL, RAC3, RAC1, RAC2
28ITK and TCR Signaling3627.3PIK3R3, PIK3R2, PIK3R1, NCK1, VAV2, RAC3
29Reelin Pathway (Cajal-Retzius cells)3627.2LRP6, RELN, CNR1, CNR2, KIF21A, KIF1B
30Development_IGF-1 receptor signaling4126.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
31NF-kappaB Signaling326.5PIR, REL, RELA, RELB, MYD88, PAWR
32Immune response_IL-2 activation and signaling pathway4126.0PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, REL
33TGF-beta signaling pathway2026.0RBL2, RBX1, RBL1, MYC, BMP2, BMP4
34ECM-receptor interaction2025.4RELN, VWF, VTN, SDC1, SDC2, SDC4
35Glioma2025.2PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
36Immune response_IFN gamma signaling pathway4124.5PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
37Translation Non-genomic (rapid) action of Androgen Receptor1024.5PIK3R1, REL, RELA, RELB, RAF1, FZD1
38Development Prolactin receptor signaling1024.3PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, RELA
39Development_Prolactin receptor signaling4124.3PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, RELA
40DNA Damage324.0RECQL, RECQL4, KIAA1967, RBBP8, NBN, BRCA1
41Basal cell carcinoma2023.3BMP2, BMP4, LEF1, AXIN1, AXIN2, FZD1
42Development_VEGF signaling and activation4123.1PIK3CB, PIK3CA, PIK3R3, PIK3R2, REL, RELA
43Endometrial cancer2020.8PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
44Transcription PPAR Pathway1019.5PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, NCOA1
45Immune response IFN gamma signaling pathway1017.8PIK3R3, RAP1A, RAPGEF1, ATF2, JAK2, ITPR1
46Signal transduction AKT signaling1015.0PIK3CB, PIK3CD, PIK3R3, PIK3R2, PIK3R1, REL
47Pancreatic cancer2014.4PIK3R3, PIK3R2, PIK3R5, BRCA2, RALGDS, RAC3
48Development EGFR signaling pathway1011.8BTC, CBL, EREG, NFKBIE
49Cytoskeletal Signaling3INFNCK1, WASF2, WASL, RCC1, RCC2, PCM1
50MAPK Signaling36INFZNF354A, PIK3R3, PIK3R2, PIK3R1, KIT, KITLG

Compounds for genes affiliated with Carcinoma

Sources:
32Novoseek , 34PharmGKB, 9DrugBank, 42Tocris Bioscience, 18HMDB
See all sources

Compounds related to carcinoma according to GeneDecks:

(show top 50)    (show all 440)
idCompoundScoreTop Affiliating Genes
1phospholipid32 INFPIKFYVE, PIK3R1, , PDE4A, VWF, SFTPB
2haloperidol32 34 9 9 INFPIK3C2A, REN, VIP, BDNF, KCNH2, SCD
3serine32 INFPIKFYVE, PIGR, PIK3CB, PIK3CD, PIM2, PIK3CA
4glutamine32 INFPIK3CG, NCAM1, NCOA1, NCOA2, NCOA3, PDE4A
5gaba32 42 INFNCAM1, RELN, CNR1, CNTF, GCG, VIM
64-hydroxynonenal32 18 INFGCLC, MYC, MYB, RALBP1, PARP1, CHKA
7glutamate32 INFPIK3CB, PI4K2A, PIK3CA, PIK3R1, NCAM1, NCOA1
8actinomycin d32 93.5PIK3CA, PIK3CG, NCL, PDE4A, RETN, CNN1
9fibrinogen32 68.3PIK3CB, PIP, PIK3C2A, KLF6, RECK, RETN
10ly29400232 57.4PIK3CB, PIK3CA, PIK3R1, PIK3C2A, PIK3CG, PI3
11rapamycin32 42 56.1PIK3CG, PIN1, PIM1, KIT, KITLG, PCK2
12aspirin32 34 18 54.9PDE4A, CNR1, KITLG, VWF, VTN, PCNA
13formaldehyde32 18 46.8KIT, VWF, PCNA, RB1, SELE, SELL
14agarose32 42.6CNBP, KIT, KITLG, VWF, SFTPD, SERPINA7
15hydrocortisone32 9 9 42.7REN, KITLG, SERPINA6, VIM, BMP6, LIF
16urea32 9 18 9 38.1PIK3C2A, RETN, VTN, PCK2, GC, SERPINA7
17cgmp32 34.3PDE1A, PDE1C, PDE3A, PDE3B, PDE4A, REN
18mitomycin c32 32.8VWF, PCK2, PCNA, RB1, NBN, BRCA1
19geldanamycin32 9 9 32.3PIK3R1, PIK3CG, PIM1, SETD2, BRAF, VEGFA
20kainate32 30.0NCAM1, REST, CNR1, BLVRB, CLU, BDNF
21anisomycin32 42 9 9 32.6PIK3CG, MYC, RAF1, BDNF, LDLR, MTOR
22bortezomib32 9 9 31.6SETD2, BRCA1, VEGFA, VCP, MYC, BID
23morphine32 9 9 30.5CNR1, VIP, UGT1A, UGT1A1, UGT1A6, UGT1A9
24bleomycin32 9 9 29.6SFTPB, SFTPC, BRCA1, BRCA2, LIG3, BLMH
25neopterin32 27.0NAGLU, PAH, LGALS3BP, CHKB, MX1, LCN2
26acetaminophen32 34 9 18 9 30.8PCNA, GCG, GC, NAT2, MYC, BCL2L1
27rottlerin32 42 26.7PIK3R1, PIK3CG, VCAM1, RAC1, PARP1, XIAP
28prostaglandin f2alpha32 25.1PDE4A, SFTPB, SERPINE1, VIP, LPL, RAF1
29diphenyleneiodonium32 25.0NCF2, SETD2, SERPINF1, VEGFA, VCAM1, RAC1
30ccl432 24.9S100B, XCL1, ATF3, MMP13, MET, IL12B
31xanthine32 18 25.6PIK3C2A, PDE4A, SGCB, PCK2, NAT2, LPO
32kininogen32 24.4REN, VWF, VTN, SELP, SERPINC1, SERPINF2
33phosphoserine32 18 25.2PIN1, REG1A, CNTN2, BRCA1, VCL, RAF1
34mitoxantrone32 9 9 24.3LPO, BIRC5, BCL2, MVP, MTOR, ATM
35nicotine32 34 9 9 24.7RB1, SELL, BMP2, BIRC5, UGT1A, UGT1A1
36sulforaphane32 21.5PIK3CG, RB1, PARP1, KEAP1, UGT1A, UGT1A1
37sp 60012532 42 19.2PIK3CG, VCAM1, BID, BIK, BIRC2, BIRC3
38nmda32 42 INFPIK3CA, LRP1, NCAM1, PDE4A, RELN, REST
39glycosaminoglycan32 INFLRP1, VTN, SERPINE2, SERPINC1, SERPIND1, NAGLU
40estrogen32 INFZNF673, PIK3CB, PIP, PIK3R1, PIAS1, KLF10
41adenylate32 INFPIK3CA, PIK3CG, KLF6, NCL, PDE3A, PDE3B
42lysine32 INFPIAS1, NCL, NCOA1, NCOA2, RECK, REL
43sodium nitroprusside32 INFPIK3C2A, PDE4A, REN, SGCB, VWF, PCNA
44caffeine32 34 9 18 9 INFPIK3R1, PDE3B, PDE4A, PCNA, VIP, NAT1
45carbon32 INFCNR1, CNR2, VWF, VTN, SFTPD, PCNA
46histamine32 18 INFPIK3CA, PI3, NCAM1, PDE3B, PDE4A, SGCB
47fatty acid32 INFPIK3C2A, PI3, LRP1, NCOA1, PDE3B, RECK
48arginine32 INFPIK3CA, PIAS1, PIK3C2A, RFC1, NCL, NCOA2
49chloroquine32 34 9 9 INFKIT, VTN, SERPINC1, BRCA1, BMP6, RAF1
50sialic acid32 INFNCAM1, RECK, GCNT1, RBP4, SELL, SELPLG

GO Terms for genes affiliated with Carcinoma

Sources:
12Gene Ontology
See all sources

Cellular components related to carcinoma according to GeneDecks:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:005615INF, KL, REG3A, RELN, REN, CNTF
2neuronal cell bodyGO:043025INFPI4K2A, NCOA2, CNTF, CNTN2, SERPINE2, BRS3
3nucleoplasmGO:005654INFZNF217, PIAS1, PIN1, RFC1, RFC4, RFC5
4plasma membraneGO:005886INFPIK3CD, PIK3R1, PIK3C2B, PIK3C2A, PIK3CG, PIGU
5apical plasma membraneGO:016324INFPIP, , SEPT7, BST2, NAALADL1, BMPR2
6extracellular regionGO:005576INFPIGR, PIP, LRPAP1, KL, NCAM1, PDCD1LG2
7cytoplasmGO:005737INFZNF146, PIAS3, PIR, PIM3, PIK3R5, PIDD
8integral to plasma membraneGO:005887INFPIGR, PI4K2A, LRP1, LRP12, LRRC32, KL
9perinuclear region of cytoplasmGO:04847155.7PIKFYVE, LRAT, PDE4A, PCSK9, BUB1B, GC
10external side of plasma membraneGO:00989738.0NCAM1, KIT, VWF, SELL, SELP, SERPINA5
11transcription factor complexGO:00566732.3KLF4, RELA, RBL2, RBM14, NAA15, LMO2
12membrane raftGO:04512129.9PIKFYVE, PI4K2A, SGCA, BTK, SELE, BSG
13basolateral plasma membraneGO:01632328.9LIN7C, UMOD, CHRM3, P2RY1, P2RY2, P2RY4
14focal adhesionGO:00592527.0ZNF384, RFWD2, KIF22, BRCA1, LPP, LPXN
15cell-cell junctionGO:00591124.7SGCA, VCL, RAP1B, CLDN5, CLIC4, PAK1
16platelet alpha granule lumenGO:03109320.4VWF, SERPINF2, SERPINA1, SERPINE1, SERPING1, VEGFA
17endoplasmic reticulumGO:005783INFPIK3C2B, , LRP6, LRPAP1, NCEH1, NCK1
18cytosolGO:005829INFPIKFYVE, PIK3CB, PIK3CD, PI4K2A, PIK3CA, PIK3R3
19nucleolusGO:005730INFZNF146, ZNF148, ZNF384, ZNF207, PINX1, KLF5
20membraneGO:016020INFPIK3R5, PIK3CG, RFFL, PDE3B, PDE4A, RECK
21cell surfaceGO:009986INFLRP6, LRPAP1, NCAM1, CNTN2, KISS1R, SFRP1
22nucleusGO:005634INFZNF444, ZNF197, ZNF510, ZNF267, ZNF382, ZNF410
23proteinaceous extracellular matrixGO:005578INFPI3, RELN, VWF, SFRP1, SERPINA1, VEGFA
24extracellular matrixGO:031012INFVWF, VTN, SFRP1, SFRP2, PCSK6, SERPINE2
25mitochondrionGO:005739INFPI4K2A, PINX1, RERE, KIF1B, KIAA0101, PCK2

Biological processes related to carcinoma according to GeneDecks:

(show top 50)    (show all 101)
idNameGO IDScoreTop Affiliating Genes
1agingGO:007568INF, KL, NCF2, CNR1, SERPINA7, SERPINF1
2response to hypoxiaGO:001666INFSFTPB, SERPINA1, VEGFA, VCAM1, BNIP3, MYOCD
3signal transductionGO:007165124.5PIK3CB, PIK3CD, PIDD, LRP12, SH3BP2, SH3GL2
4blood coagulationGO:00759671.6PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, PIK3R5
5cell adhesionGO:00715565.4NCAM1, RELN, CNTN2, KITLG, VWF, VTN
6immune responseGO:00695553.3NCR3, PDCD1LG2, CNR2, KIR2DS5, KIR2DL1, KIR2DL3
7innate immune responseGO:04508752.4PIK3CD, PIK3CG, PIN1, NCF2, RELA, SFTPD
8inflammatory responseGO:00695450.8PIK3CD, PIK3CG, NCR3, RELA, CNR2, KIT
9protein phosphorylationGO:00646849.7PIK3CD, PIM2, PIM3, PIM1, RET, VRK1
10anti-apoptosisGO:00691645.2PIM2, PIK3CA, SH3GLB1, RELA, GCLC, SERPINB9
11platelet activationGO:03016844.6PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, PIK3R5
12positive regulation of apoptotic processGO:04306544.4LRP6, NCOA1, REST, CNR1, KIAA1967, SFRP1
13angiogenesisGO:00152542.1PIK3CA, PIK3CG, KLF5, NCL, PDE3B, WARS
14nerve growth factor receptor signaling pathwayGO:04801141.6PIK3CB, PIK3CA, PIK3R2, PIK3R1, SH3GL2, NDN
15mitotic cell cycleGO:00027841.4NDC80, RFC1, RFC4, RFC5, KIF23, RCC2
16cytokine-mediated signaling pathwayGO:01922140.7PIAS1, PIN1, KLF6, NCAM1, RELA, KIT
17induction of apoptosisGO:00691739.2KLF10, PDCD5, PCSK9, NACC1, NAIF1, BOK
18transcription initiation from RNA polymerase II promoterGO:00636735.3NCOR1, NCOR2, RBPJ, RBL1, SERPINE1, VDR
19cell surface receptor signaling pathwayGO:00716634.3BSG, MYD88, LIFR, BIRC2, BIRC3, KHDRBS1
20positive regulation of cell migrationGO:03033532.4RET, VIL1, VEGFA, MYLK, BMP2, KDR
21protein autophosphorylationGO:04677732.1PIM1, KIT, VRK1, VRK2, BMX, CLK1
22epidermal growth factor receptor signaling pathwayGO:00717331.7PIK3CA, PIK3R1, PIK3C2A, SH3GL2, PDE1A, PDE1C
23regulation of apoptotic processGO:04298131.5KIAA1324, SEPT4, BRCA1, VCP, LMNA, RAF1
24cell cycle arrestGO:00705031.5BTG4, RB1, NBN, SESN1, VASH1, MYC
25insulin receptor signaling pathwayGO:00828631.2PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, PIK3C2A
26positive regulation of I-kappaB kinase/NF-kappaB cascadeGO:04312330.6PIM2, REL, RELA, BST2, LPAR1, MYD88
27transforming growth factor beta receptor signaling pathwayGO:00717930.0KLF10, NCOR1, NCOR2, RBL1, SERPINE1, MYC
28fibroblast growth factor receptor signaling pathwayGO:00854329.5PIK3CA, PIK3R1, KL, PDE1A, PDE1C, BRAF
29leukocyte migrationGO:05090029.4PIK3CB, PIK3CA, PIK3R2, PIK3R1, SELL, SELP
30platelet degranulationGO:00257627.4VWF, SELP, SERPINF2, SERPINA1, SERPINE1, SERPING1
31positive regulation of NF-kappaB transcription factor activityGO:05109226.9RELA, BTK, MYD88, CLU, BCL10, CHUK
32activation of cysteine-type endopeptidase activity involved in apoptotic processGO:00691925.2PDCD6, VCP, BOK, MYC, BCL2L10, BCL2L11
33Toll signaling pathwayGO:00806325.1RELA, BTK, MYD88, CHUK, UBB, UBC
34cellular response to hypoxiaGO:07145624.4SFRP1, RBX1, VLDLR, VHL, VEGFA, LMNA
35positive regulation of peptidyl-tyrosine phosphorylationGO:05073123.7RELN, KITLG, VTN, VEGFA, VEGFB, LIF
36DNA repairGO:006281INFRFC1, RFC4, RFC5, RECQL, RECQL4, REV1
37heart developmentGO:007507INFPCNA, RBP4, RB1CC1, VLDLR, VCAM1, VCAN
38positive regulation of cell proliferationGO:008284INFKLF5, REG1A, CNBP, CNTF, KIT, SFRP1
39positive regulation of transcription from RNA polymerase II promoterGO:045944INFZNF148, LRP6, KLF4, KLF6, NCK1, NCOA1
40cell proliferationGO:008283INFPIM2, PIM1, , KLF10, REG3A, RETNLB
41small molecule metabolic processGO:044281INFPIKFYVE, PIK3CB, PIK3CD, PI4K2A, PIK3CA, PIK3R3
42negative regulation of apoptotic processGO:043066INFPIM3, PIDD, PIK3CG, PIM1, PDE3A, RELA
43positive regulation of transcription, DNA-dependentGO:045893INFPIM2, PIAS1, LRP6, KLF4, KLF5, KLF6
44virus-host interactionGO:019048INFPIK3R1, RELA, SGTA, VRK2, BUB1, BTRC
45gene expressionGO:010467INFNCOR1, NCOR2, WARS, WARS2, PCBP2, RBM5
46response to lipopolysaccharideGO:032496INFNCF2, CNR1, CNR2, SFTPB, SFTPC, SELE
47response to drugGO:042493INF, NCF2, PDE3A, PDE4A, REN, SFRP1
48response to estradiol stimulusGO:032355INFNCOA1, SFRP4, GC, SERPINA1, BRCA2, VDR
49negative regulation of cell growthGO:030308INFRERG, SFRP1, SFRP2, RB1, SERPINE2, SERTAD3
50negative regulation of cell proliferationGO:008285INFPIM2, PINX1, KLF10, KLF4, NDN, RERG

Molecular functions related to carcinoma according to GeneDecks:

(show all 28)
idNameGO IDScoreTop Affiliating Genes
1receptor activityGO:004872INFLRP1, RET, KIR2DL1, KIR2DL3, SEMA3A, SEMA3E
2protein bindingGO:005515INFZNF217, ZNF148, ZNF652, ZNF639, PIKFYVE, PIK3CB
3protein homodimerization activityGO:04280375.5LRP6, SH3GLB1, PDCD6, KIT, VWF, SFTPC
4protein kinase bindingGO:01990146.4RELA, KIF11, RB1CC1, VIM, RAD9A, LLGL1
5transcription factor bindingGO:00813441.2PIM1, RELA, REST, RB1, RBL1, NBN
6protein serine/threonine kinase activityGO:00467441.0PIM2, PIK3CA, PIM3, PIK3CG, PIM1, VRK1
7growth factor activityGO:00808339.2REG1A, CNTF, KITLG, BTC, VGF, VEGFA
8chromatin bindingGO:00368236.3NCOA1, NCOA2, NCOA3, RELA, REST, RCC1
9transcription regulatory region DNA bindingGO:04421235.6ZNF217, ZNF639, KLF4, NCOR1, RELA, REST
10signal transducer activityGO:00487134.8KL, NCOA1, NCOA2, NCOA3, PDCD1, VOPP1
11protein kinase activityGO:00467233.3PIK3CG, BUB1, BUB1B, BRAF, RAF1, LIMK1
12structural molecule activityGO:00519829.8NCR3LG1, BVES, SEMG2, SEPT4, SEPT7, VCL
13heparin bindingGO:00820129.6ZNF146, LRPAP1, VTN, SFRP1, PCSK6, SELL
14ubiquitin protein ligase bindingGO:03162529.4RELA, PCBP2, RB1, RBX1, BRCA1, MYOD1
15electron carrier activityGO:00905528.1NCF2, UQCR11, SDHB, SDHC, SDHD, UGDH
16hormone activityGO:00517924.7KL, RETN, RETNLB, GCG, VIP, UTS2
17double-stranded DNA bindingGO:00369024.4ZNF148, KLF4, KLF6, MYC, RAD51, RAD51AP1
18protein tyrosine kinase activityGO:00471324.0RET, KIT, BTK, LMTK3, BMX, KDR
19beta-catenin bindingGO:00801321.6BTRC, VCL, BCL9, BCL9L, LEF1, SALL1
20sequence-specific DNA bindingGO:043565INFZNF148, RERE, NANOG, VDR, MYC, RARG
21identical protein bindingGO:042802INFSH3GL2, SH3GLB1, RELA, CNTN2, SFRP1, PCSK9
22enzyme bindingGO:019899INFPIAS3, PIAS1, RFC5, NCOA1, KIAA1967, PCBP2
23receptor bindingGO:005102INFLRP6, NCK1, REN, RCHY1, GCG, SELPLG
24calcium ion bindingGO:005509INFLRP1B, LRP1, , PDCD6, RET, SGCA
25cytokine activityGO:005125INFCNTF, KITLG, NAMPT, VEGFA, BMP1, BMP2
26ATP bindingGO:005524INFPIKFYVE, PIK3CB, PIK3CD, PI4K2A, PIM2, PIK3CA
27sequence-specific DNA binding transcription factor activityGO:003700INFZNF444, ZNF197, ZNF217, ZNF148, ZNF202, ZNF135
28protein heterodimerization activityGO:046982INFBRAF, VEGFA, VEGFB, BOK, BNIP3, BNIP3L

Sources for Carcinoma

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS